Micra Leadless Pacemaker for Bridge Use After Explantation of Infected Permanent Pacemaker System: a Case Report
Overview
Overview
Journal
J Surg Case Rep
Publisher
Oxford University Press
Specialty
General Surgery
Date
2021 Apr 26
PMID
33897997
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The extraction of a pacemaker (PM) lead may cause tricuspid regurgitation; however, in cases of device infection, surgical intervention or immediate PM system replacement is undesirable in the short term to prevent reinfection. We describe a case where Micra leadless PM was used as a bridge procedure to ensure an adequate period for antibacterial therapy and later replaced with a permanent PM system in the setting of PM pocket infection.
References
1.
Kypta A, Blessberger H, Kammler J, Lambert T, Lichtenauer M, Brandstaetter W
. Leadless Cardiac Pacemaker Implantation After Lead Extraction in Patients With Severe Device Infection. J Cardiovasc Electrophysiol. 2016; 27(9):1067-71.
DOI: 10.1111/jce.13030.
View
2.
Park S, Gentry 3rd J, Varma N, Wazni O, Tarakji K, Mehta A
. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation. JACC Clin Electrophysiol. 2018; 4(11):1421-1428.
DOI: 10.1016/j.jacep.2018.07.011.
View
3.
Givon A, Vedernikova N, Luria D, Vatury O, Kuperstein R, Feinberg M
. Tricuspid Regurgitation following Lead Extraction: Risk Factors and Clinical Course. Isr Med Assoc J. 2016; 18(1):18-22.
View
4.
Nielsen J, Gerdes J, Varma N
. Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J. 2015; 36(37):2484-90.
DOI: 10.1093/eurheartj/ehv060.
View
5.
Nakatani S, Ohara T, Ashihara K, Izumi C, Iwanaga S, Eishi K
. JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis. Circ J. 2019; 83(8):1767-1809.
DOI: 10.1253/circj.CJ-19-0549.
View